AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 151 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,655,000 | +92.3% | 1,100,775 | -4.7% | 0.01% | +100.0% |
| Q2 2022 | $8,659,000 | -21.2% | 1,154,623 | -4.4% | 0.01% | -14.3% |
| Q1 2022 | $10,986,000 | +45.0% | 1,207,306 | +11.9% | 0.01% | +75.0% |
| Q4 2021 | $7,577,000 | -47.0% | 1,079,337 | -14.0% | 0.00% | -50.0% |
| Q3 2021 | $14,299,000 | -28.0% | 1,254,330 | +1.1% | 0.01% | -33.3% |
| Q2 2021 | $19,866,000 | -5.2% | 1,240,824 | +5.8% | 0.01% | -14.3% |
| Q1 2021 | $20,964,000 | +24.3% | 1,173,166 | -6.0% | 0.01% | +40.0% |
| Q4 2020 | $16,870,000 | +19.1% | 1,248,698 | +3.7% | 0.01% | +11.1% |
| Q3 2020 | $14,169,000 | -20.7% | 1,203,871 | -0.6% | 0.01% | -35.7% |
| Q2 2020 | $17,877,000 | +13.0% | 1,211,168 | +3.4% | 0.01% | 0.0% |
| Q1 2020 | $15,815,000 | -29.0% | 1,171,499 | +27.2% | 0.01% | -12.5% |
| Q4 2019 | $22,260,000 | +111200.0% | 920,981 | +86867.0% | 0.02% | – |
| Q3 2019 | $20,000 | -93.8% | 1,059 | -90.4% | 0.00% | – |
| Q2 2019 | $324,000 | +9.1% | 10,979 | +75.4% | 0.00% | – |
| Q1 2019 | $297,000 | -84.2% | 6,260 | -87.9% | 0.00% | -100.0% |
| Q4 2018 | $1,875,000 | -68.2% | 51,925 | -45.7% | 0.00% | -60.0% |
| Q3 2018 | $5,889,000 | +38.2% | 95,672 | +51.7% | 0.01% | +25.0% |
| Q2 2018 | $4,260,000 | +100.3% | 63,067 | +60.8% | 0.00% | +100.0% |
| Q1 2018 | $2,127,000 | -57.0% | 39,222 | -52.6% | 0.00% | -50.0% |
| Q4 2017 | $4,945,000 | +375.9% | 82,766 | +287.2% | 0.00% | +300.0% |
| Q3 2017 | $1,039,000 | -7.4% | 21,377 | +0.1% | 0.00% | 0.0% |
| Q2 2017 | $1,122,000 | -87.8% | 21,345 | -89.5% | 0.00% | -87.5% |
| Q1 2017 | $9,218,000 | +73.9% | 203,277 | +45.1% | 0.01% | +60.0% |
| Q4 2016 | $5,302,000 | +527.5% | 140,079 | +526.1% | 0.01% | +400.0% |
| Q3 2016 | $845,000 | +391.3% | 22,372 | +127.9% | 0.00% | – |
| Q2 2016 | $172,000 | -30.6% | 9,815 | -51.7% | 0.00% | – |
| Q1 2016 | $248,000 | -23.0% | 20,332 | +54.0% | 0.00% | – |
| Q4 2015 | $322,000 | +187.5% | 13,206 | +109.8% | 0.00% | – |
| Q3 2015 | $112,000 | +14.3% | 6,294 | +13.7% | 0.00% | – |
| Q2 2015 | $98,000 | -58.3% | 5,538 | -26.3% | 0.00% | – |
| Q1 2015 | $235,000 | +12.4% | 7,514 | +5.1% | 0.00% | – |
| Q4 2014 | $209,000 | +480.6% | 7,150 | +311.6% | 0.00% | – |
| Q3 2014 | $36,000 | +1700.0% | 1,737 | +1851.7% | 0.00% | – |
| Q2 2014 | $2,000 | -97.5% | 89 | -97.6% | 0.00% | – |
| Q1 2014 | $80,000 | +17.6% | 3,774 | +0.1% | 0.00% | – |
| Q4 2013 | $68,000 | – | 3,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|